$NUMD

Nu-Med Plus, Inc.

CIK:0001543637|SEC Filings

Statements of Operations - USD ($)	3 Months Ended		6 Months Ended
Statements of Operations - USD ($)	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Income Statement [Abstract]
Revenue	$ 0	$ 0	$ 0	$ 0
Operating expenses
General and administrative expense	8,073	5,469	12,906	11,174
Rent expense	210	0	610	0
Professional and consulting fees	14,273	4,950	22,192	17,945
Total operating expenses	22,556	10,419	35,708	29,119
Operating Loss	(22,556)	(10,419)	(35,708)	(29,119)
Other income (expense)
Other Income	45,000	0	45,000
Interest expense	(2,774)	(1,246)	(5,500)	(2,479)
Total other income (expense)	42,226	(1,246)	39,500	(2,479)
Net income (loss) before income tax	19,670	(11,665)	3,792	(31,598)
Income tax expense	0	0	0	0
Net income (loss)	$ 19,670	$ (11,665)	$ 3,792	$ (31,598)
Basic earnings per share	$ 0	$ 0	$ 0	$ 0
Diluted earnings per share	$ 0	$ 0	$ 0	$ 0
Weighted average common shares outstanding - basic (in Shares)	83,548,469	83,548,469	83,548,469	83,548,469
Weighted average common shares outstanding - diluted (in Shares)	83,548,469	83,548,469	83,548,469	83,548,469

Statements of Cash Flows - USD ($)	6 Months Ended
Statements of Cash Flows - USD ($)	Jun. 30, 2026	Jun. 30, 2025
Cash flows from operating activities:
Net income (loss)	$ 3,792	$ (31,598)
Adjustment to reconcile net income (loss) to net cash used in operating activities:
Prepaid expenses	(250)	(300)
Accounts payable	(14,294)	12,164
Accounts payable-related party	0	19,450
Accrued expense	5,500	(1,226)
Net cash used in operating activities	(5,252)	(1,510)
Cash flows from investing activities:
Net cash provided by investing activities	0	0
Cash flows from financing activities
Net cash provided by financing activities	10,000	0
Net change in cash	4,748	(1,510)
Cash at beginning of period	661	2,373
Cash at end of period	5,409	863
Supplemental schedule of cash flow information
Cash paid for interest	0	0
Cash paid for income tax	$ 0	$ 0

Condensed Balance Sheets - USD ($)	Jun. 30, 2026	Dec. 31, 2025
Current assets
Cash	$ 5,409	$ 661
Prepaid expenses	7,500	7,250
Total current assets	12,909	7,911
Total assets	12,909	7,911
Current liabilities
Accounts payable	33,909	48,203
Convertible note payable	100,000	100,000
Notes payable – related party	122,500	112,500
Accrued expenses	23,509	18,009
Total current liabilities	280,395	279,189
Long-term liabilities	0	0
Total liabilities	280,395	279,189
Commitments and contingencies	0	0
Stockholders' deficit
Preferred stock; $0.001 par value; 10,000,000 authorized; no shares issued and outstanding, as of June 30, 2026 and December 31, 2025, respectively.	0	0
Common stock; $0.001 par value; 90,000,000 authorized; 83,548,469 and 83,548,469 shares issued and outstanding, as of June 30, 2026 and December 31, 2025, respectively.	83,549	83,549
Additional paid-in capital	9,594,687	9,594,687
Accumulated deficit	(9,945,722)	(9,949,514)
Total stockholders' deficit	(267,486)	(271,278)
Total liabilities and stockholders' deficit	12,909	7,911
Related Party
Current liabilities
Accounts payable – related party	$ 477	$ 477